Cohance Lifesciences Limited
COHANCE
Rangering i aksjer
#6487
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aksjekurs
$4.80
Markedsverdi
$1.84B
Endring (1 dag)
-5.65%
Endring (1 år)
-59.47%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
Aksjeprishistorikk for Cohance Lifesciences Limited (COHANCE)
Høyeste sluttskurs: $12.03 den 2025-06-01
Laveste sluttskurs: $1.66 den 2020-03-01
Laveste sluttskurs: $1.66 den 2020-03-01
Aksjeprishistorikk for Cohance Lifesciences Limited fra 2020 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2025 | -17.22% |
| 2024 | 76.00% |
| 2023 | 43.09% |
| 2022 | -12.38% |
| 2021 | 15.52% |
| 2020 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
